These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Characterization of enzyme motions by solution NMR relaxation dispersion. Loria JP, Berlow RB, Watt ED. Acc Chem Res; 2008 Feb 27; 41(2):214-21. PubMed ID: 18281945 [Abstract] [Full Text] [Related]
26. Structural insight into the binding diversity between the human Nck2 SH3 domains and proline-rich proteins. Liu J, Li M, Ran X, Fan JS, Song J. Biochemistry; 2006 Jun 13; 45(23):7171-84. PubMed ID: 16752908 [Abstract] [Full Text] [Related]
29. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain. Brasher BB, Roumiantsev S, Van Etten RA. Oncogene; 2001 Nov 22; 20(53):7744-52. PubMed ID: 11753652 [Abstract] [Full Text] [Related]
32. The identification of conserved interactions within the SH3 domain by alignment of sequences and structures. Larson SM, Davidson AR. Protein Sci; 2000 Nov 22; 9(11):2170-80. PubMed ID: 11152127 [Abstract] [Full Text] [Related]
33. Recognition of lysine-rich peptide ligands by murine cortactin SH3 domain: CD, ITC, and NMR studies. Rubini C, Ruzza P, Spaller MR, Siligardi G, Hussain R, Udugamasooriya DG, Bellanda M, Mammi S, Borgogno A, Calderan A, Cesaro L, Brunati AM, Donella-Deana A. Biopolymers; 2010 Nov 22; 94(3):298-306. PubMed ID: 19921743 [Abstract] [Full Text] [Related]
34. Prediction and structural characterization of an independently folding substructure in the src SH3 domain. Yi Q, Bystroff C, Rajagopal P, Klevit RE, Baker D. J Mol Biol; 1998 Nov 22; 283(1):293-300. PubMed ID: 9761691 [Abstract] [Full Text] [Related]
35. Energetics of binding the mammalian high mobility group protein HMGA2 to poly(dA-dT)2 and poly(dA)-poly(dT). Cui T, Wei S, Brew K, Leng F. J Mol Biol; 2005 Sep 23; 352(3):629-45. PubMed ID: 16109425 [Abstract] [Full Text] [Related]
36. Interactions between the Fyn SH3-domain and adaptor protein Cbp/PAG derived ligands, effects on kinase activity and affinity. Solheim SA, Petsalaki E, Stokka AJ, Russell RB, Taskén K, Berge T. FEBS J; 2008 Oct 23; 275(19):4863-74. PubMed ID: 18721137 [Abstract] [Full Text] [Related]
37. Crystallographic structure of the SH3 domain of the human c-Yes tyrosine kinase: loop flexibility and amyloid aggregation. Martín-García JM, Luque I, Mateo PL, Ruiz-Sanz J, Cámara-Artigas A. FEBS Lett; 2007 May 01; 581(9):1701-6. PubMed ID: 17418139 [Abstract] [Full Text] [Related]
38. The high-resolution NMR structure of a single-chain chimeric protein mimicking a SH3-peptide complex. Candel AM, Conejero-Lara F, Martinez JC, van Nuland NA, Bruix M. FEBS Lett; 2007 Feb 20; 581(4):687-92. PubMed ID: 17275816 [Abstract] [Full Text] [Related]
39. Structural comparison of the unstable drkN SH3 domain and a stable mutant. Bezsonova I, Singer A, Choy WY, Tollinger M, Forman-Kay JD. Biochemistry; 2005 Nov 29; 44(47):15550-60. PubMed ID: 16300404 [Abstract] [Full Text] [Related]
40. Protein stabilization by specific binding of guanidinium to a functional arginine-binding surface on an SH3 domain. Zarrine-Afsar A, Mittermaier A, Kay LE, Davidson AR. Protein Sci; 2006 Jan 29; 15(1):162-70. PubMed ID: 16373478 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]